美通社

2024-11-05 11:00

6th Asia Pacific Chemsex Symposium (APCS) 2024 Opens in Bangkok with Over 300 Participants and Launch of the Gilead HIV Community Scholarship Program

BANGKOK, Nov. 5, 2024 /PRNewswire/ -- For the first time, the Asia Pacific Chemsex Symposium (APCS) has moved from Taipei to Bangkok, marking a new chapter in its mission to expand the understanding of pleasures and harms related to chemsex in the Asia-Pacific context, and see the possibilities to optimize chemsex care. This sixth gathering of APCS, hosted by the Institute for HIV Research and Innovation (IHRI, Thailand), Service Workers in Group (SWING, Thailand), the University of Malaya (Malaysia), and HIV Education and Research Taiwan (HEArT, Taiwan), has attracted more than 300 participants and features the theme "Pleasures, Policies, and Possibilities." The symposium has become an essential forum for engaging diverse voices and discussing the unique complexities of chemsex in the region.

Dr. Stephane Wen-Wei Ku, HIV Education and Research (HEArT), Taiwan; Khun Surang Janyam, Service Workers in Group (SWING), Thailand; Dr. Nittaya Phanuphak, Institute of HIV Research and Innovation (IHRI), Thailand; and Dr. Iskandar Raja Azwa, University of Malaya, Malaysia.
Dr. Stephane Wen-Wei Ku, HIV Education and Research (HEArT), Taiwan; Khun Surang Janyam, Service Workers in Group (SWING), Thailand; Dr. Nittaya Phanuphak, Institute of HIV Research and Innovation (IHRI), Thailand; and Dr. Iskandar Raja Azwa, University of Malaya, Malaysia.

Since its inception in 2019, APCS has brought together community members, healthcare professionals, CSOs/NGOs, advocates, researchers, policymakers, donors and technical  agencies, providing a safe, culturally sensitive space to discuss issues around HIV, mental health, and harm reduction. This year's discussions focus on advancing HIV/STI prevention, improving mental health, and promoting evidence-based, rights affirming chemsex harm reduction interventions and policies tailored to the needs of key populations.

"A core goal of APCS is to empower and facilitate community leaders and stakeholders to collaborate and share resources across borders," said Dr. Nittaya Phanuphak, Convenor of APCS 2024 Organizing Committee. "We aim to spotlight initiatives that respect the diverse  social dynamics and policy environments across the region to minimize harm and foster impactful change."

A major highlight of this year's symposium is the launch of the Gilead HIV Community Scholarship Program, an initiative that recognizes the vital work of community-based organizations (CBOs) in chemsex-related harm reduction, HIV prevention, and community care. This program supports and amplifies the voices of those who are closest to the communities affected by chemsex and HIV.

The HIV Community Scholars, supported by Gilead Sciences, are invited to attend APCS 2024 to present their innovative projects and exchange learnings and ideas with like-minded peers and experts. Key projects presented include:

  • Abstract #27016: "High, Fun, and Safe: A Community-Centered HIV and Harm Reduction Intervention for the MSM Chemsex Community in Vietnam" by Phung Ba Thanh from Vietnam's Lighthouse organization. This oral presentation focuses on an HIV and harm reduction intervention tailored to the needs of MSM communities engaged in chemsex.
  • Abstract #30128: "Walking on Eggshells: Experiences and Perceptions Towards Accessing HIV Services Among Filipino MSM Engaged in Chemsex during the Philippines' War on Drugs" by Rodenie Arnaiz Olete and Kate Leyritana. This poster sheds light on the challenges Filipino MSM face in accessing HIV services amid stigma, emphasizing the development of culturally tailored resources to address local needs
  • Abstract #35077: "Successes and Challenges in Piloting Screening, Brief Intervention, and Referral to Treatment (SBIRT) Services for Sexualized Drug Users Among Young Key Populations in Yangon, Myanmar" led by Myo Myat Aung and a Myanmar-based team. This poster presentation emphasizes peer support and harm reduction strategies for young people in Yangon.

"Community-based organizations are in the frontline of addressing HIV prevention and harm reduction," said Alain Chan, Executive Director, Medical Affairs of Gilead Patient Solutions. "We're proud to see the launch of the Gilead HIV Community Scholars Program, honoring our community partners through supporting their travel to participate in the APCS. We hope they can leverage this opportunity to learn and exchange and be inspired by each other."

The APCS 2024 symposium will continue through November 7 at the Benjasiri Ballroom 1-3, 5th Floor, Novotel Sukhumvit 20, with discussions on the latest research, policy initiatives, and community-driven solutions for chemsex-related health challenges in the Asia-Pacific region.

For media inquiries, please contact:
Phat Parkpien, Consultant, APCO
pparkpien@apcoworldwide.com
Tel: 081 858 6376

About Asia Pacific Chemsex Symposium (APCS)
APCS is an annual event dedicated to fostering meaningful dialogues, sharing valuable insights, and encouraging collaboration to tackle the complex, locally relevant challenges of Chemsex. Our focus includes key populations, HIV/STI prevention, mental health, and harm reduction. Join us in this important endeavor to make a difference. Our collaborators include Institute for HIV Research and Innovation (IHRI, Thailand), Service Workers in Group (SWING, Thailand), the University of Malaya (Malaysia), and HIV Education and Research Taiwan (HEArT, Taiwan).

About Gilead HIV Community Scholarship Program
The Gilead HIV Community Scholars Program aims to empower community-based organizations (CBOs) dedicated to HIV prevention and harm reduction. By providing scholarships to select scholars, the program highlights the vital role these organizations play in addressing the complexities of HIV care, particularly among key populations. Scholars will have the opportunity to attend the Asia-Pacific Chemsex Symposium, where they can share their innovative work, engage with experts, and collaborate with peers committed to advancing HIV care and support in their communities.

 

source: Asia Pacific Chemsex Symposium

【香港好去處】2025去邊最好玩?etnet為你提供全港最齊盛事活動,所有資訊盡在掌握!► 即睇

人氣文章
最近7天
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
3
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
4
高息定存 | 花旗3個月港元定存息加至4厘,信銀國際3.88厘
5
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
6
一本萬利 | 2025年的五個「勿」(有片)
7
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
8
互聯支付 | 黃俊碩:轉數快與IBPS互聯支付所產生的發展契機
9
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
10
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
11
電騙 | 黃俊碩:多管齊下,防治內地留學生受騙
12
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
13
洪灝專訪 | 淘寶衝擊巨大,港樓價未反映大周期拐點(有片)
14
專訪|洪灝:美股更大跌幅在前面,恐需習慣4%通脹(有片)
15
習近平應約與特朗普通電話,特:冀盡快與習見面
16
新世界 | 摩通:新世界若債務違約或打開行業「潘朵拉盒子」
17
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
18
【FOCUS】螺絲殼裏做道場,DeepSeek致勝啟示
19
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
20
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
21
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
22
雷賢達觀點 | 香港篇:恒指年波幅料六千點,港須全面融入大灣區
23
DeepSeek推出即上蘋果中國區榜首,能力直追OpenAI
24
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
25
高息定存 | 一周高息合集,部分銀行逆市加息,南商3個月加至3.8厘
26
港股 | 蕭猷華:春節假後,恒指逐步上望21000點
27
特朗普就職 | 特朗普上台後行動列表
28
馬斯克明拆特朗普台,指其星際之門計劃「假大空」
29
【FOCUS】侵侵呼籲全球「降息」,日銀祭18年最激進加息
30
高息定存 | 富邦一周港元定存高達9.88厘,一個月4.88厘
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【蛇年行大運 新年好賞「飾」】etnet賞太歲開運趨吉避凶神器

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老